The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment sequence for hormone receptor-positive HER2-negative advanced breast cancer: Results of a retrospective analysis of Russian patients diagnosed with aBC in 2014-2021.
 
Marina Stenina
Speakers' Bureau - Lilly; Roche
 
Lyudmila Zhukova
Consulting or Advisory Role - AstraZeneca/MedImmune; BIOCAD; Novartis; Roche
Speakers' Bureau - AstraZeneca/MedImmune/Spirogen; BIOCAD; Lilly; Novartis; Pfizer; R-Pharm; Roche
Travel, Accommodations, Expenses - R-Pharm
 
Daniil Stroyakovskiy
Speakers' Bureau - AstraZeneca; BioCad; Bristol-Myers Squibb; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche; Roche
 
Vera V. Karaseva
No Relationships to Disclose
 
Sergei Tjulandin
Stock and Other Ownership Interests - RosPharmTech
Consulting or Advisory Role - AstraZeneca; BioCad; Lilly; Novartis; Roche
Speakers' Bureau - AstraZeneca; Merck Sharp & Dohme; Novartis; Pierre Fabre; R-Pharm; Roche
Research Funding - Abbvie (Inst); Bristol Myers Squibb Foundation (Inst); Eisai (Inst); Merck (Inst); Novartis (Inst); SERVIER